Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Teva Pharmaceutical Industries Limited American Depositary Shares
(NY:
TEVA
)
16.94
+0.07 (+0.41%)
Official Closing Price
Updated: 7:00 PM EDT, May 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Teva Pharmaceutical Industries Limited American Depositary Shares
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
27
28
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
July 27, 2022
Good morning, investor! Wednesday starts with a breakdown of the biggest pre-market stock movers for traders to keep an eye on!
Via
InvestorPlace
Why Is F45 Training Holdings Down By 56%? Here Are 28 Stocks Moving In Wednesday's Pre-Market Session
July 27, 2022
Gainers Dave Inc. (NASDAQ: DAVE) rose 56.9% to $0.9826 in pre-market trading. Dave is expected to release its second quarter 2022 financial results on Thursday, August 11, 2022.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 26, 2022
Gainers
Via
Benzinga
What Is Going on With Teva Pharmaceuticals (TEVA) Stock Today?
July 12, 2022
TEVA stock, already trading far below its prior peak, may come under pressure in the near future due to the threat of ongoing litigation.
Via
InvestorPlace
Analyst Ratings for Teva Pharmaceutical Indus
June 14, 2022
Within the last quarter, Teva Pharmaceutical Indus (NYSE:TEVA) has observed the following analyst ratings:
Via
Benzinga
Why Teva Pharmaceuticals Stock Is Soaring After Hours
July 26, 2022
Teva Pharmaceutical Industries (NYSE: TEVA) shares are surging in Tuesday's after-hours session after the company reported better-than-expected financial results.
Via
Benzinga
Teva Reports Second Quarter 2022 Financial Results
July 26, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
7 Growth Stocks to Buy on the Dip
July 22, 2022
These are the best growth stocks to buy on the dip. A, CDNS, GXTG, IVSG, IQV, PAYX, and SNPS are poised to deliver impressive returns.
Via
InvestorPlace
Will Bed Bath & Beyond (BBBY) Stock Really Fall to $1?
July 12, 2022
Bed Bath & Beyond (BBBY) stock is in the news today after an incredibly bearish analyst said the retailer's shares will fall to $1 a piece.
Via
InvestorPlace
Teva Reaches Agreement With San Francisco to Settle Opioid-Related Claims
July 12, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
New York Attorney General Says Teva Tried To Evade Accountability On Opioid Crisis: Report
July 12, 2022
Reuters reported that New York's attorney general said Teva Pharmaceutical Industries Ltd (NY
Via
Benzinga
Teva Announces Appointment of New Global R&D and Chief Medical Officer
July 01, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva to Host Conference Call to Discuss Second Quarter 2022 Financial Results at 8 a.m. ET on July 27, 2022
June 29, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva Announces Promising Interim Results From Its Study PEARL, About the Impact of AJOVY® (fremanezumab)
June 24, 2022
From
Teva Pharmaceutical Industries Ltd.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022
June 14, 2022
Upgrades
Via
Benzinga
Teva Announces Settlement with Aurobindo Resolving AUSTEDO® (deutetrabenazine) Patent Dispute
June 09, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
New Real-World Data Evaluating AJOVY® (fremanezumab-vfrm) Injection Use in Patients With Migraine Presented at 2022 American Headache Society Annual Meeting
June 09, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2022 American Headache Society Annual Meeting
June 09, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Direct Relief, the National Association of Free and Charitable Clinics and Teva Pharmaceuticals Partner to Advance Access to Behavioral Health Services
June 08, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Golden Cross Appears Before Teva Pharmaceutical Indus Investors
May 27, 2022
If history is any guide, there may be good fortune ahead for shares of Teva Pharmaceutical Indus (NYSE:TEVA). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be...
Via
Benzinga
Teva, Allergan Settle Opioid Lawsuit With West Virginia
May 25, 2022
U.S. affiliate of Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has reached an agreement with the Attorney General of West Virginia that settles the state's opioid-related claims.
Via
Benzinga
Teva Reaches Agreement With West Virginia to Settle the State’s Opioid-Related Claims
May 25, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva Presents New Long-Term AUSTEDO® (deutetrabenazine) Tablets Data at 2022 American Psychiatric Association Annual Meeting
May 23, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients
May 17, 2022
Via
Benzinga
BofA Upgrades Teva Pharmaceutical On Possible Opioid Deal
May 17, 2022
Prospects of a global opioid deal getting done in 2022 suggest a “potential path to upside” for Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA) stock, according to BofA Securities.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2022
May 17, 2022
Via
Benzinga
United Kingdom first to grant licence for Teva’s ophthalmology biosimilar Ongavia (ranibizumab)▼
May 17, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva to Present Latest Research From Neurology Portfolio at the 2022 American Psychiatric Association Annual Meeting
May 17, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva Announces New Findings Highlighting Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Address Asthma Treatment Challenges
May 17, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
4 Analysts Have This to Say About Teva Pharmaceutical Indus
May 12, 2022
Over the past 3 months, 4 analysts have published their opinion on Teva Pharmaceutical Indus (NYSE:TEVA) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
27
28
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.